Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (91-100 of 345) with videos related to

Pageof 35
Sort By:
BMJ (Clinical Research Ed.)|July 12, 2012
Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort studyDaniela Di Giuseppe, Lars Alfredsson, Matteo Bottai, et al.
Clinical Pharmacology and Therapeutics|June 2, 2022
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational DataAndrei Barbulescu, Johan Askling, Saedis Saevarsdottir, et al.
The European Respiratory Journal|July 30, 2016
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in SwedenElizabeth V Arkema, Johan Grunewald, Susanna Kullberg, et al.
Scandinavian Journal of Gastroenterology|December 17, 2008
Early-life exposures associated with antibiotic use and risk of subsequent Crohn's diseaseHans Hildebrand, Petter Malmborg, Johan Askling, et al.
European Heart Journal|September 25, 2015
Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcomeÄngla Mantel, Marie Holmqvist, Tomas Jernberg, et al.
Annals of the Rheumatic Diseases|August 22, 2017
Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritisÄngla Mantel, Marie Holmqvist, Tomas Jernberg, et al.
RMD Open|October 21, 2022
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smokingKaterina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, et al.
Annals of the Rheumatic Diseases|November 23, 2021
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
RMD Open|November 23, 2023
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritisHannah Bower, Thomas Frisell, Daniela di Giuseppe, et al.
Arthritis and Rheumatism|September 8, 2011
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritisLotta Ljung, Julia F Simard, Lennart Jacobsson, et al.
Pageof 35

Showing results (91-100 of 345) with videos related to

Sort By:
Pageof 35
BMJ (Clinical Research Ed.)|July 12, 2012
Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort studyDaniela Di Giuseppe, Lars Alfredsson, Matteo Bottai, et al.
Clinical Pharmacology and Therapeutics|June 2, 2022
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational DataAndrei Barbulescu, Johan Askling, Saedis Saevarsdottir, et al.
The European Respiratory Journal|July 30, 2016
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in SwedenElizabeth V Arkema, Johan Grunewald, Susanna Kullberg, et al.
Scandinavian Journal of Gastroenterology|December 17, 2008
Early-life exposures associated with antibiotic use and risk of subsequent Crohn's diseaseHans Hildebrand, Petter Malmborg, Johan Askling, et al.
European Heart Journal|September 25, 2015
Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcomeÄngla Mantel, Marie Holmqvist, Tomas Jernberg, et al.
Annals of the Rheumatic Diseases|August 22, 2017
Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritisÄngla Mantel, Marie Holmqvist, Tomas Jernberg, et al.
RMD Open|October 21, 2022
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smokingKaterina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, et al.
Annals of the Rheumatic Diseases|November 23, 2021
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
RMD Open|November 23, 2023
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritisHannah Bower, Thomas Frisell, Daniela di Giuseppe, et al.
Arthritis and Rheumatism|September 8, 2011
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritisLotta Ljung, Julia F Simard, Lennart Jacobsson, et al.
Pageof 35